GreenPeps
Tirzepatide 60 mg is a formulation containing tirzepatide, a dual GIP and GLP-1 receptor agonist used in adults for glycemic control in type 2 diabetes and, in approved indications, chronic weight management. It works by influencing insulin and glucagon regulation, slowing gastric emptying, and increasing satiety. Supplied as a sterile lyophilized powder containing 60 mg per vial. Use only as prescribed and under the supervision of a qualified healthcare professional.
Retatrutide 60 mg is an investigational synthetic peptide that acts as a triple agonist targeting the GLP-1, GIP, and glucagon receptors. It is being studied for its potential effects on metabolic regulation, glycemic control, appetite, energy expenditure, and weight management. Supplied as a lyophilized powder containing 60 mg per vial. Retatrutide is an investigational compound and is not currently approved for general medical use.
GHK-Cu 100 mg is a research-grade formulation containing Copper Tripeptide-1 (GHK-Cu), a naturally occurring copper-binding peptide studied for its potential role in tissue repair, collagen synthesis, cellular regeneration, and skin-related research. Supplied as a sterile lyophilized powder containing 100 mg per vial. For research use only. Not for human or animal consumption.
GLOW is a research peptide formulation containing BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg), for a total of 70 mg per vial. This combination is designed for laboratory research involving cellular repair, angiogenesis, tissue remodeling, and regenerative biological pathways. Supplied as a lyophilized powder. For research use only. Not for human or animal consumption.